Automating regulatory submissions for life sciences
Company is active
Event Year: 2025
Company is active
Event Year: 2025
Scoop is developing AI-powered agents designed to accelerate the drug trial process within the life sciences industry. Their technology automates the often tedious and time-consuming tasks of consolidating and preparing documents necessary for Investigational New Drug (IND) submissions. Currently, biotechnology companies dedicate significant time, often spanning months, to compile reports from various contractors and internal teams simply to meet filing requirements and initiate their crucial first-in-human trials. Scoop aims to streamline this process, enabling faster and more efficient drug development.
Scoop is developing AI-powered agents designed to accelerate the drug trial process within the life sciences industry. Their technology automates the often tedious and time-consuming tasks of consolidating and preparing documents necessary for Investigational New Drug (IND) submissions. Currently, biotechnology companies dedicate significant time, often spanning months, to compile reports from various contractors and internal teams simply to meet filing requirements and initiate their crucial first-in-human trials. Scoop aims to streamline this process, enabling faster and more efficient drug development.
Total Raised: Unknown (Y Combinator backed)
Last Round: Fall 2025
Total Raised: Unknown (Y Combinator backed)
Last Round: Fall 2025
B2B
B2B
B2B
B2B
Team size: 2
Hiring: No
Team size: 2
Hiring: No